Skip to main content

Table 2 Clinical presentation on admission

From: Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging

Symptoms and signs EES group BVS group Test p value Sig.
No. = 40 No. = 20
Chest pain Negative 2 (5%) 0 (0%) 1.034 0.309 NS
Positive 38 (95%) 20 (100%)
Dyspnea Negative 29 (72.5%) 17 (85%) 1.165 0.281 NS
Positive 11 (27.5%) 3 (15%)
BP Normal 40 (100%) 20 (100%)
SBP Mean ± SD 112.98 ± 3.5 114.67 ± 3.22 1.809 0.076 NS
Range 100–120 100–120
DBP Mean ± SD 74.52 ± 1.7 74.80 ± 1.34 0.643 0.523 NS
Range 70–80 70–80
Pulse Mean ± SD 74.05 ± 5.81 72.45 ± 4.97 1.053b 0.297 NS
Range 60–86 65–76
Murmur No 29 (72.5%) 16 (80.0%) 0.400a 0.527 NS
MR 11 (27.5%) 4 (20.0%)
  1. BP blood pressure, SBP systolic blood pressure, DBP diastolic blood pressure, MR mitral regurgitation, NS non-significant, S significant
  2. aChi-square test
  3. bIndependent t test